Literature DB >> 18640173

Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats.

Miguel Molina-Hernández1, Norma Patricia Téllez-Alcántara, Julián Pérez-García, Jorge Iván Olivera-Lopez, M Teresa Jaramillo-Jaimes.   

Abstract

Minocycline produces antidepressant-like actions in male rats tested in the forced swimming test (FST) and synergizes with several glutamate receptor antagonists. However, the limbic regions implicated in the antidepressant-like actions of minocycline are unknown. The objective of the present study was to test the potential antidepressant activity of nucleus accumbens infusions of minocycline alone or combined with antidepressant drugs or with several glutamate receptor antagonists, using the time-sampling method in the FST. The results show that intra-NAcc infusions of minocycline reduced immobility (1.0 microg, P<0.05; 1.5 microg, P<0.05) by increasing climbing (1.0 microg, P<0.05; 1.5 microg, P<0.05) in the FST. Likewise, systemic injections of desipramine (P<0.05), fluoxetine (P<0.05) or several glutamate receptor antagonists: EMQMCM (P<0.05), MTEP (P<0.05) or dizocilpine (P<0.05) combined with intra-nucleus accumbens infusions of vehicle produced antidepressant-like actions. The subthreshold dose of intra-nucleus accumbens infusions of minocycline combined with systemic injections of subthreshold doses of desipramine (P<0.05) or EMQMCM (P<0.05) or MTEP (P<0.05) or dizocilpine (P<0.05) produced antidepressant-like actions. It is concluded that intra-NAcc infusions of minocycline alone or combined with systemic injections of desipramine or with systemic injections of several glutamate receptor antagonists produced antidepressant-like actions in the FST.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18640173     DOI: 10.1016/j.pnpbp.2008.06.010

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  14 in total

Review 1.  Mood disorders and obesity: understanding inflammation as a pathophysiological nexus.

Authors:  Joanna K Soczynska; Sidney H Kennedy; Hanna O Woldeyohannes; Samantha S Liauw; Mohammad Alsuwaidan; Christina Y Yim; Roger S McIntyre
Journal:  Neuromolecular Med       Date:  2010-12-17       Impact factor: 3.843

Review 2.  Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?

Authors:  Karen Wager-Smith; Athina Markou
Journal:  Neurosci Biobehav Rev       Date:  2010-09-29       Impact factor: 8.989

Review 3.  Minocycline: therapeutic potential in psychiatry.

Authors:  Olivia M Dean; João Data-Franco; Francesco Giorlando; Michael Berk
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

4.  Minocycline affects cocaine sensitization in mice.

Authors:  Hu Chen; Tolga Uz; Hari Manev
Journal:  Neurosci Lett       Date:  2009-02-04       Impact factor: 3.046

5.  Alterations in mGlu5 receptor expression and function in the striatum in a rat depression model.

Authors:  Li-Min Mao; John Q Wang
Journal:  J Neurochem       Date:  2018-02-08       Impact factor: 5.372

6.  Toward an anti-inflammatory strategy for depression.

Authors:  Shawn Hayley
Journal:  Front Behav Neurosci       Date:  2011-04-13       Impact factor: 3.558

7.  Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2x2 clinical trial.

Authors:  Jonathan Savitz; Sheldon Preskorn; T Kent Teague; Douglas Drevets; William Yates; Wayne Drevets
Journal:  BMJ Open       Date:  2012-02-22       Impact factor: 2.692

Review 8.  Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial.

Authors:  Olivia May Dean; Michael Maes; Melanie Ashton; Lesley Berk; Buranee Kanchanatawan; Atapol Sughondhabirom; Sookjareon Tangwongchai; Chee Ng; Nathan Dowling; Gin S Malhi; MIchael Berk
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-12-26       Impact factor: 2.582

Review 9.  Therapeutic Strategies for Treatment of Inflammation-related Depression.

Authors:  Miroslav Adzic; Zeljka Brkic; Milos Mitic; Ester Francija; Milica J Jovicic; Jelena Radulovic; Nadja P Maric
Journal:  Curr Neuropharmacol       Date:  2018-01-30       Impact factor: 7.363

10.  Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition.

Authors:  M-L Wong; A Inserra; M D Lewis; C A Mastronardi; L Leong; J Choo; S Kentish; P Xie; M Morrison; S L Wesselingh; G B Rogers; J Licinio
Journal:  Mol Psychiatry       Date:  2016-04-19       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.